James Stambaugh, VP Clinical Affairs at Intersect ENT, Inc. (XENT), sold 5,000 shares at $15.33 ($77K) on 2016-07-18, disclosed to the SEC on 2016-07-19.
Open-market sale of $77k XENT by VP Clinical Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| XENT | SELL | 2016-06-14 | $7K | — | Filing → |
| XENT | SELL | 2015-07-21 | $366K | — | Filing → |
| XENT | SELL | 2015-05-11 | $66K | — | Filing → |